Clearance Summary
iSage Rx (iSage Rx Basal Insulin Titration) received FDA 510(k) clearance under submission number K161865, sponsored by Isag Rx, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 2017-03-07.
- Submission: K161865
- Applicant / Sponsor: Isag Rx, Inc.
- Clearance pathway: Traditional
- Review panel: Anesthesiology
- Device class: Class II
- Regulation citation: 21 CFR 868.1890
- Decision date: 2017-03-07
Classification & Regulation
This clearance is catalogued under FDA product code NDC and 21 CFR 868.1890, within the Anesthesiology review panel as a Class II device.